/
Pre-filters 178471  variants Pre-filters 178471  variants

Pre-filters 178471 variants - PowerPoint Presentation

garcia
garcia . @garcia
Follow
27 views
Uploaded On 2024-02-03

Pre-filters 178471 variants - PPT Presentation

Short listed in Phase I analysis 69 variants 993453 coding variants Short listed in Phase II analysis Short listed in Phase III analysis 45 variants 60 variants de novo 67 ID: 1044508

variants phase variantsclass genes phase variants genes variantsclass listed number trios raps breakdown variant workflow variantsshort

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Pre-filters 178471 variants" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Pre-filters178471 variantsShort listed in Phase I analysis69 variants993453 coding variantsShort listed in Phase II analysisShort listed in Phase III analysis45 variants60 variantsde novo67 variantsHomozygous51 variantsCompound Heterozygous22 variantsXLR9 variantsHeterozygous (inherited)25 variantsClass 227 variantsClass 3152 variantsClass 414 variantsClass 53 variantsPrimary Molecular diagnoses10Undiagnosed14ResultsSchematic breakdown of number of variants in 24 trios in different steps of the RaPS workflow. In Phase I, the number of genes filtered is different in each trio. Phase II is composed of genes from GGD2P (1643genes) and OMIM Morbid Genes (7737 genes) databases and is standard across all trios. The RaPS variant analysis workflow is phased to prioritise likely causative gene variants. Note that compound heterozygous and homozygous variants are counted once. Number of variants in 24 triosNumber of variants in 24 patientsSupplementary Figure 3: Variant breakdown overview